Intestinal Cell News Volume 6.37 | Sep 25 2020

    0
    31






    2020-09-25| ICN 21.28


    Intestinal Cell News by STEMCELL Technologies
    Vol. 6.37 – 25 September, 2020
    TOP STORY

    Enteroendocrine
    Cells Couple Nutrient Sensing to Nutrient Absorption by Regulating Ion Transport

    Researchers found that peptide YY was required in the small intestine to maintain normal electrophysiology in the presence of vasoactive intestinal polypeptide, a potent stimulator of ion secretion classically produced by enteric neurons.
    [Nature Communications]

    Full Article


    Activate, expand, and differentiate your cells with cytokines, chemokines, and growth factors from STEMCELL Technologies.
    PUBLICATIONSRanked by the impact factor of the journal

    Inhibition
    of Protein Tyrosine Phosphatase Receptor Type F Suppresses Wnt Signaling in Colorectal Cancer

    Scientists investigated the role of protein tyrosine phosphatase receptor type F (PTPRF), a receptor-type tyrosine phosphatase, in regulating Wnt signaling in colorectal cancer. Knockdown of PTPRF decreased cell proliferation in patient-derived primary colon cancer cells and established colorectal cancer cell lines.
    [Oncogene]

    Abstract

    Discovery
    of a Novel Dual-Target Inhibitor against RSK1 and MSK2 to Suppress Growth of Human Colon Cancer

    The authors identified a novel dual-target inhibitor, APIO-EE-07, that could block both RSK1 and MSK2 kinase activity in a dose-dependent manner. APIO-EE-07 inhibited cell growth and induced apoptosis and also increased expression of Bax as well as cleaved caspase-3 and -PARP in colon cancer cells by downregulating RSK1 and MSK2 downstream targets, including CREB and ATF1.
    [Oncogene]

    Abstract

    Aspirin
    Rescues Wnt-Driven Stem-Like Phenotype in Human Intestinal Organoids and Increases the Wnt Antagonist Dickkopf-1

    Investigators evaluated aspirin-mediated effects on phenotype and stem cell markers in intestinal organoids derived from mouse and human familial adenomatous polyposis patients. colorectal cancer cell lines were used to study effects on motility, invasion, Wnt signalling and epithelial-mesenchymal transition.
    [Cellular and Molecular Gastroenterology and Hepatology]

    Full Article

    A Novel Epigenetic Regulation of circFoxp1 on Foxp1 in Colon Cancer Cells

    Researchers investigated the role of circFoxp1 in colon cancer and the regulatory mechanism between circFoxp1 and Foxp1. 78 human colon tumor tissues and the matched paracancerous tissues were collected. Quantitative polymerase chain reaction, immunohistochemistry, quantitative methylation-specific PCR, chromatin immunoprecipitation assay, CCK-8 assay, and Tumor xenograft in nude mice were performed.
    [Cell Death & Disease]

    Full Article

    Heme
    Oxygenase 1 Protects Human Colonocytes against ROS Formation, Oxidative DNA Damage and Cytotoxicity Induced By Heme Iron, but Not Inorganic Iron

    Scientists investigated the genotoxic and cytotoxic effects of heme iron versus inorganic iron in human colonic epithelial cells, human colorectal cancer cell lines and murine intestinal organoids.
    [Cell Death & Disease]

    Full Article

    STING
    Controls Intestinal Homeostasis through Promoting Antimicrobial Peptide Expression in Epithelial Cells

    Stimulator of interferon genes(STING) promote intestinal epithelial cells REG3γ expression to inhibit enteric infection and intestinal inflammation, thus, maintaining the intestinal homeostasis.
    [FASEB Journal]

    Full Article

    Rab13 Regulates sEV Secretion in Mutant KRAS
    Colorectal Cancer Cells

    Researchers showed that Rab13 regulated the secretion of small extracellular vesicles (sEVs) corresponding to both traditional exosomes and a novel subset of vesicles containing both β1-integrin and Rab13. They found that exposure of recipient cells to sEVs from KRAS mutant donor cells increased proliferation and tumorigenesis and that knockdown of Rab13 blocked these effects.
    [Scientific Reports]

    Full Article

    Berberine Inhibits Colorectal Tumor Growth by Suppressing SHH Secretion

    Berberine promotes the degradation of SHH mRNA in colorectal cancer cells, interrupting the paracrine Hedgehog signaling pathway activity thus suppresses the colorectal cancer growth.
    [Acta Pharmacologica Sinica]

    Abstract

    Age-Associated
    Mitochondrial DNA Mutations Cause Metabolic Remodeling That Contributes to Accelerated Intestinal Tumorigenesis

    Investigators showed that both normal crypts and tumors underwent metabolic remodeling in response to oxidative phosphorylation deficiency by upregulating the de novo serine synthesis pathway.
    [Nature Cancer]

    Abstract


    Tumors Are 3D. Your 2D Model May Not Give You All The Answers. Learn More.
    REVIEWS

    Host–Microbiota Maladaptation in Colorectal Cancer

    The authors discuss the host–microbiota interactions in colorectal cancer that have been reported so far, with particular focus on mechanisms that are linked to intestinal barrier disruption, genotoxicity and deleterious inflammation.
    [Nature]

    Abstract

    Cell Fate Specification and Differentiation in the Adult Mammalian Intestine

    New approaches such as single-cell transcriptomics and the use of organoid models have led to the identification of the signals that guide fate specification of stem cell progeny into the six intestinal cell lineages.
    [Nature Reviews Molecular Cell Biology]

    Abstract

    INDUSTRY AND POLICY NEWS

    Boehringer Ingelheim And Mirati Therapeutics Announce Clinical Collaboration To Study BI 1701963, A SOS1::pan-KRAS Inhibitor In Combination With MRTX849, A KRAS G12C Selective Inhibitor

    Boehringer Ingelheim and Mirati Therapeutics, Inc. announced a clinical collaboration to evaluate the combination of BI 1701963, a SOS1::pan-KRAS inhibitor blocking KRAS independent of mutation type, and MRTX849, a KRAS G12C selective inhibitor in patients with solid tumors that harbor the KRAS G12C mutation.
    [Mirati Therapeutics, Inc.]

    Press Release

    FEATURED EVENT

    10
    Million Reasons to Defeat Cancer 2020 – Abbott World Summit

    October 13 – October 14
    Virtual


    > See All Events

    JOB OPPORTUNITIES

    Staff
    Scientist – Molecular Diagnostics & Experimental Therapeutics

    City of Hope – Monrovia, California, United States

    Senior
    Scientist – Gut Microbiome and Gastrointestinal Physiology

    Chr. Hansen A/S – Hørsholm, Denmark

    Postdoctoral
    Associate – The Relationship between Diet, Metabolism, Microbiome, and Colorectal Cancer

    Baylor College of Medicine – Houston, Texas, United States

    Scientist – Gastric Cancer

    The University of Arizona – Tucson, Arizona, United States

    Post Doctoral Fellow – Digestive Diseases

    Emory University – Atlanta, Georgia, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Science News Intestinal Cell News
    Archives
    Contact Us
    Intestinal Cell News Twitter